that is a great article from C.E.N's May issue - it's nice to go back for a read & great too see Paul Watt's got so much to say in it.
Also the friendly reminder that in 2010 there where 60 peptide drugs worldwide in market with sales approaching $13B....
I just like this line from Aileron's CEO (who stitched the $1.2B Roche deal last year) when talking about the accelerated interest from large pharmaceutical companies & the race to form large R&D deals with peptide foccused JR's.
"They understand that if you can unlock certain fundamental limitations of peptide therapeutics you might have the largest superclass of drugs that the industry has ever generated."
:-):-)
.
PYC Price at posting:
6.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)